Dopamine

cholecystokinin ; Homo sapiens







63 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 33794246 Does endogenous cholecystokinin modulate alcohol intake? 2021 Aug 1 2
2 19793020 A review of smoking behavior and smokers evidence (chemical modification, inducing nicotine metabolism, and individual variations by genotype: dopaminergic function and personality traits). 2009 2
3 17109076 CSF cholecystokinin, gamma-aminobutyric acid and neuropeptide Y in pathological gamblers and healthy controls. 2007 1
4 17365745 Cholecystokinin C-45T polymorphism and smoking cessation in women. 2007 Jan 2
5 16738800 CCK and NPY as anti-anxiety treatment targets: promises, pitfalls, and strategies. 2006 Oct 1
6 15740988 Cholecystokinin (CCK) and the CCKA receptor gene polymorphism, and smoking behavior. 2005 Feb 28 2
7 15837012 Polymorphisms of the cholecystokinin gene promoter region in suicide victims in Japan. 2005 May 28 4
8 14691070 Association of cholecystokinin-A receptor gene polymorphism with alcohol dependence in a Japanese population. 2004 Jan-Feb 3
9 12777967 Cholecystokinin, cholecystokinin-A receptor and cholecystokinin-B receptor gene polymorphisms in Parkinson's disease. 2003 Jun 3
10 12790157 Cholecystokinin receptor subtypes: role in the modulation of anxiety-related and reward-related behaviours in animal models. 2003 May 1
11 11967633 Brain potential signs of slowed stimulus processing following cholecystokinin in Parkinson's disease. 2002 Apr 7
12 12116760 [Involvement of the neuropeptide cholecystokinin in the mechanisms of regulation of emotions and craving]. 2002 3
13 12198366 Investigation of quantitative trait loci in the CCKAR gene with susceptibility to alcoholism. 2002 Aug 2
14 12424552 SR146131, a cholecystokinin-A receptor agonist, antagonizes prepulse inhibition deficits produced by dizocilpine and DOI. 2002 Nov 2
15 11513220 Polymorphisms of the CCK, CCKAR and CCKBR genes: an association with alcoholism study. 2001 Jul 2
16 11549403 Linked polymorphisms (-333G>T and -286A>G) in the promoter region of the CCK-A receptor gene may be associated with schizophrenia. 2001 Sep 20 1
17 10803770 Genetic polymorphism of the CCK gene in patients with alcohol withdrawal symptoms. 2000 Apr 2
18 10893485 Novel polymorphisms of the human cholecystokinin A receptor gene: an association analysis with schizophrenia. 2000 Apr 3 1
19 9885794 Antipsychotic potential of CCK-based treatments: an assessment using the prepulse inhibition model of psychosis. 1999 Feb 4
20 10220011 No association between C-45T polymorphism in the Sp1 binding site of the promoter region of the cholecystokinin gene and alcoholism. 1999 Feb 22 4
21 10235270 Genetic association between alcohol withdrawal symptoms and polymorphism of CCK gene promoter. 1999 Apr 3
22 10668930 Association between polymorphism of the cholecystokinin gene and idiopathic Parkinson's disease. 1999 Nov 2
23 9622381 A new genetic variant in the Sp1 binding cis-element of cholecystokinin gene promoter region and relationship to alcoholism. 1998 May 2
24 9663451 Cholecystokinergic innervation of nucleus accumbens subregions. 1998 3
25 15616622 Cholecystokinin as a target for neuropsychiatric drugs. 1998 Aug 1
26 9574843 Cholecystokinin increases extracellular dopamine overflow in the anterior nucleus accumbens via CCK(B) receptors in the VTA assessed by in vivo voltammetry. 1997 Feb 2
27 8761988 PD-135158, a CCKB receptor antagonist, microinjected into the nucleus accumbens and the expression of conditioned rewarded behavior. 1996 May 10 2
28 8951986 Acquisition of conditioned reward blocked by intra-accumbens infusion of PD-140548, a CCKA receptor antagonist. 1996 Nov 5
29 7479342 Interaction of CCKB receptors with amphetamine in responding for conditioned rewards. 1995 2
30 7491953 Cholecystokinin receptors. 1995 Nov 1
31 7640325 Improved event-related potential signs of selective attention after the administration of the cholecystokinin analog ceruletide in healthy persons. 1995 May 15 8
32 8748063 Cholecystokinin in psychiatric research: a time for cautious excitement. 1995 Sep-Oct 1
33 7914685 Nucleus accumbens dopamine-CCK interactions in psychostimulant reward and related behaviors. 1994 Summer 1
34 8185154 Cholecystokinin modulates dopamine-mediated behaviors. Differential actions in medial posterior versus anterior nucleus accumbens. 1994 Mar 23 1
35 7987278 [Localization and role of cholecystokinin and its receptors in the functional organization of the basal ganglia]. 1993 1
36 8248241 Regulation by the neuropeptide cholecystokinin (CCK-8S) of protein phosphorylation in the neostriatum. 1993 Dec 1 1
37 1611514 Morphine place conditioning is differentially affected by CCKA and CCKB receptor antagonists. 1992 Feb 14 1
38 21776120 Dopamine and obsessive disorder: a clinical study with cck and methyl phenidate. 1992 Apr 1
39 1686250 [Is cholecystokinin a biological support in panic attacks?]. 1991 Sep-Oct 1
40 1792008 Cholecystokinin-induced anxiety: how is it reflected in studies on exploratory behaviour? 1991 Winter 2
41 1956989 Concentration of cholecystokinin in cerebrospinal fluid is decreased in psychosis: relationship to symptoms and drug response. 1991 2
42 2048219 Cholecystokinin-dopamine interactions. 1991 Jun 2
43 1978324 Analysis of expression of cholecystokinin in dopamine cells in the ventral mesencephalon of several species and in humans with schizophrenia. 1990 Nov 1
44 2274639 Cholecystokinin, dopamine and schizophrenia. 1990 1
45 2546180 CCK modulation of cerebellar afferents: dopaminergic involvement. 1989 1
46 2688364 Presence of cholecystokinin mRNA in dopamine cells in the ventral mesencephalon of a human with schizophrenia. 1989 Nov 1
47 2765186 Nucleus accumbens cholecystokinin (CCK) can either attenuate or potentiate amphetamine-induced locomotor activity: evidence for rostral-caudal differences in accumbens CCK function. 1989 Aug 2
48 2918999 Antagonism of cholecystokinin function in the rostral and caudal nucleus accumbens: differential effects on brain stimulation reward. 1989 Feb 13 3
49 3208120 Cholecystokinin antagonist lorglumide reverses chronic haloperidol-induced effects on dopamine neurons. 1988 Nov 8 2
50 2819952 Cholecystokinin-induced inhibition of dopamine neurotransmission: comparison with chronic haloperidol treatment. 1987 1